NOTE's STI Acquisition: A 6x EV/EBITDA Moat Play in a High-Growth Defense Niche

The acquisition of STI is a classic move to buy a durable moat in a high-quality, growing market. STI is the UK's leading manufacturer of advanced electronic solutions for defense, a position that grants it a formidable competitive advantage. Its long-standing relationships with global defense primes and its operation across all defense domains-air, land, cyber, and marine-create a high barrier to entry for competitors. This isn't a commodity business; it's a mission-critical partnership where reliability and proven capability are paramount. For a value investor, this is the kind of entrenched position that compounds well over decades.

The strategic fit is clear. The UK defense electronics market is projected to grow at an 8.61% CAGR through 2035, a powerful tailwind for any player with a strong order book and technological edge. STI's expected 2026 revenue of GBP 60 million and its two high-technology production sites represent a tangible expansion into this lucrative segment. By acquiring STI, NOTE gains not just revenue, but a platform with established capabilities in advanced PCBA, box build, and testing. This complements NOTE's existing operations and creates a stronger European player, as CEO Johannes Lind-Widestam noted.

Yet, the durability of this moat must be weighed against the inherent complexity of the acquisition. Adding 300 employees and two new production sites increases operational integration risk. The defense electronics sector is also subject to government procurement cycles and geopolitical shifts, which can introduce volatility. However, the market's projected growth and STI's established position suggest these are manageable friction costs, not fundamental threats to the business model. The key question is whether STI's technological capabilities and customer relationships can be leveraged to capture a growing share of that expanding pie.

From a value perspective, the price paid appears reasonable. The purchase price of GBP 72.5 million translates to an adjusted EV/EBITDA multiple of approximately 10x. In a high-growth, capital-intensive sector, this multiple suggests the market is pricing in the integration risks and the cyclical nature of defense spending. For a disciplined buyer, it represents an opportunity to acquire a leading asset in a growing market at a price that doesn't demand perfection. The real test will be whether STI's moat widens further as the UK's defense industrial strategy pushes for technological self-reliance and indigenous innovation. If so, this acquisition could become a cornerstone of NOTE's long-term compounding story.

Financial Impact and the Price Paid

The capital allocation decision here is a textbook example of disciplined, opportunistic buying. The total potential consideration of GBP 34.1 million is a meaningful but not transformative investment for NOTE's capital base. For a company with last year's sales of SEK 3.8 billion, this represents a strategic bet on a specific, high-quality niche rather than a leveraged takeover of the entire business. The initial purchase price of GBP 28.2 million on a cash/debt-free basis, with a potential earnout of up to GBP 5.9 million, implies an adjusted EV/EBITDA multiple of approximately 6x. This is a key number for a value investor.

That multiple suggests the market is pricing in the integration risk and the cyclical nature of defense spending, as noted in the earlier analysis. More importantly, it offers a tangible margin of safety relative to the business's intrinsic value. STI is expected to generate revenues of GBP 60 million in 2026, with profitability in line with NOTE's own operating margin of 9.5–10.5%. At that margin, STI's EBITDA would be in the range of GBP 5.7 to 6.3 million. Applying a 6x multiple to that EBITDA range yields a valuation of roughly GBP 34 to 38 million, which aligns closely with the total potential consideration. The math checks out.

The financing structure further supports the disciplined nature of the deal. The acquisition is being funded through a combination of credit facilities obtained from SEB totaling SEK 900 million, with a portion falling due within 12 months. This avoids a massive dilution of shareholders and maintains financial flexibility. The company's strong equity ratio of around 50% provides a solid base to absorb this new debt load without jeopardizing its financial strength.

From a compounding perspective, the setup is favorable. The purchase price is paid for a business with a strong order book and a clear path to generating cash flow that matches NOTE's own high-quality margins. The earnout component, while adding a layer of complexity, is structured to incentivize the STI team to deliver on growth targets post-acquisition. For a value investor, this is the essence of a good capital allocation: buying a durable asset at a price that reflects its risks, not its potential, and using the company's own strong cash-generating ability to fund the purchase. The price paid offers a margin of safety, and the business is expected to compound within NOTE's existing, proven operating model.

Integration, Risks, and the Long-Term Compounding Story

The true test of this acquisition lies not in the initial price or the strategic rationale, but in the execution of integration and the subsequent compounding of earnings. The operational risks are elevated. STI operates in a niche where technical complexity and long lead times are the norm, with two high-technology production sites requiring specialized management. The company's focus on mission-critical defense contracts means any integration misstep could directly impact delivery schedules and customer trust. This is a far cry from a simple operational overlay; it's a cultural and technical merge that demands careful stewardship.

Management has acknowledged the near-term pressure, reaffirming its 2026 outlook with an operating margin target of 9.5–10.5%. This provides a clear baseline, but the integration must not distract from core execution. The company's strong equity ratio of around 50% offers a buffer, but the new debt load from the SEB credit facilities adds a layer of financial discipline that must be maintained. The key risk is that integration costs and management bandwidth could dilute the company's disciplined capital allocation, which has been a hallmark of its success.

The long-term compounding story hinges on post-integration profitability and returns on capital. For a value investor, the goal is to see the combined entity generate returns that exceed NOTE's cost of capital over the next decade. The initial purchase price, even with the earnout, appears reasonable given the business's expected cash flows. The real value will be in whether STI's technological capabilities and customer relationships can be leveraged to capture a growing share of the UK's defense industrial strategy, as mentioned in the earlier analysis. If so, the margin of safety embedded in the price could widen further.

The bottom line is one of managed risk. The acquisition is a strategic bet on a durable moat in a growing market, but execution is everything. The company's reaffirmed outlook is a positive signal, showing management's confidence in navigating the near-term. The path forward requires focused integration, disciplined capital allocation, and the patience to let the moat widen over the long cycle. For a value investor, that patience is the ultimate currency.

Catalysts and What to Watch

The investment thesis for the STI acquisition now enters its execution phase. Over the next 12 to 24 months, several forward-looking events will validate or challenge the value proposition. The primary catalyst is the integration timeline itself. The deal is expected to close in mid-October 2025, meaning the first full quarter of combined operations will be Q4 2025. Investors should watch for early signs of synergy realization-whether in operational efficiencies, shared procurement, or cross-selling opportunities between STI's defense focus and NOTE's broader EMS footprint.

The most critical metrics to track are STI's quarterly performance against its 2026 targets. The company is expected to generate revenues of GBP 60 million this year, with profitability in line with NOTE's own operating margin of 9.5–10.5%. The first quarter contribution, noted to be approximately SEK 20 million, provides a baseline. The real test will be whether STI can ramp to its full annual run-rate without disrupting NOTE's core operations or its own financial discipline. Any deviation from the margin guide would signal integration friction or cost overruns.

Another key watchpoint is the earnout milestone. The potential earnout of up to GBP 5.9 million is directly tied to STI's future performance. Monitoring the progress toward these targets will provide a clear, market-based signal of whether the acquired business is compounding as expected. A successful earnout would not only lower the effective purchase price but also align the interests of the STI leadership with NOTE's long-term success.

Finally, the company's reaffirmed full-year outlook for 2026, which now incorporates STI's contribution, is a critical benchmark. The guidance for an operating margin of 9.5–10.5% must be maintained despite the integration costs and new debt load. Strong operating cash flow, as expected, will be essential to service the SEB credit facilities without compromising the balance sheet. For a value investor, the path to realizing the margin of safety embedded in the 6x EV/EBITDA multiple hinges on these specific, measurable outcomes over the coming year.